Question
The Chief Constable recently informed Member’s, through his October and November Report, of the PSNI’s Naloxone Drugs Pilot. Further information on the pilot was brought to Members’ attention through the Partnership Committee meeting in October in respect of Performance Plan Measures 3.1.2 and 3.1.3. In turn, Members would welcome:
- Clarity on the legal liability an officer could be held responsible for following the administration of the Naloxone Drug; and
- Reassurance from the Chief Constable that all officers, who have volunteered to be part of the PSNI’s Naloxone Drugs Pilot, are fully protected by adequate PSNI policies and practices.
Answer
- Officers involved in the pilot will not be subject to any additional legal liability following the administration of Naloxone. As per the current arrangements the Police Federation will support officers in the first instance. If matters were to become protracted then the Service will engage with the Police Federation to agree how support would continue. There will be no adverse impact financially on the officer concerned.
- Clinical Governance to the pilot is provided by Northern Ireland Ambulance Service, this is consistent with other functions within the Police Service. The administration of Naloxone is subject to review by the Police Service project lead and the Northern Ireland Ambulance lead.
- All officers involved in the administration of Naloxone have been trained by Extern, a recognised training provider.
- Internal governance has been provided by the Service, Health and Safety Executive, chaired by the Deputy Chief Constable. The activity has been subject to risk assessment.
- Prior to the pilot commencing best practice was established via the National Police Chiefs Council.
- Officers taking part in the pilot are fully protected by Police Service policy and practices.
Trevor Clarke - DUP